Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy

Clifford T. Gee, Edward J. Koleski, William C.K. Pomerantz

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

19F NMR spectroscopy of labeled proteins is a sensitive method for characterizing structure, conformational dynamics, higher-order assembly, and ligand binding. Fluorination of aromatic side chains has been suggested as a labeling strategy for small-molecule ligand discovery for protein-protein interaction interfaces. Using a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX, we report the first full small-molecule screen using protein-observed 19F NMR spectroscopy. Screening of 508 compounds and validation by 1H-15N HSQC NMR spectroscopy led to the identification of a minimal pharmacaphore for the MLL-KIX interaction site. Hit rate analysis for the CREB-KIX and MLL-KIX sites provided a metric to assess the ligandability or "druggability" of each interface informing future medicinal chemistry efforts. The structural information from the simplified spectra and data collection speed, affords a new screening tool for analysis of protein interfaces and discovery of small molecules. A full small-molecule screen has been achieved using protein-observed 19F NMR (PrOF NMR) spectroscopy of a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX. This study demonstrates the applicability of PrOF NMR as a tool for library screening, ligand discovery, and druggability assessment.

Original languageEnglish (US)
Pages (from-to)3735-3739
Number of pages5
JournalAngewandte Chemie - International Edition
Volume54
Issue number12
DOIs
StatePublished - Mar 16 2015

Fingerprint

CREB-Binding Protein
Nuclear magnetic resonance spectroscopy
Screening
Proteins
Molecules
Transcription factors
Ligands
Transcription Factors
Fluorination
Carrier Proteins
Labeling
Nuclear magnetic resonance

Keywords

  • biomolecular NMR
  • fluorine
  • fragment screening
  • protein-protein interactions
  • transcription

Cite this

Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy. / Gee, Clifford T.; Koleski, Edward J.; Pomerantz, William C.K.

In: Angewandte Chemie - International Edition, Vol. 54, No. 12, 16.03.2015, p. 3735-3739.

Research output: Contribution to journalArticle

@article{82067a7022614c479dfe615b9aa9ca81,
title = "Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy",
abstract = "19F NMR spectroscopy of labeled proteins is a sensitive method for characterizing structure, conformational dynamics, higher-order assembly, and ligand binding. Fluorination of aromatic side chains has been suggested as a labeling strategy for small-molecule ligand discovery for protein-protein interaction interfaces. Using a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX, we report the first full small-molecule screen using protein-observed 19F NMR spectroscopy. Screening of 508 compounds and validation by 1H-15N HSQC NMR spectroscopy led to the identification of a minimal pharmacaphore for the MLL-KIX interaction site. Hit rate analysis for the CREB-KIX and MLL-KIX sites provided a metric to assess the ligandability or {"}druggability{"} of each interface informing future medicinal chemistry efforts. The structural information from the simplified spectra and data collection speed, affords a new screening tool for analysis of protein interfaces and discovery of small molecules. A full small-molecule screen has been achieved using protein-observed 19F NMR (PrOF NMR) spectroscopy of a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX. This study demonstrates the applicability of PrOF NMR as a tool for library screening, ligand discovery, and druggability assessment.",
keywords = "biomolecular NMR, fluorine, fragment screening, protein-protein interactions, transcription",
author = "Gee, {Clifford T.} and Koleski, {Edward J.} and Pomerantz, {William C.K.}",
year = "2015",
month = "3",
day = "16",
doi = "10.1002/anie.201411658",
language = "English (US)",
volume = "54",
pages = "3735--3739",
journal = "Angewandte Chemie - International Edition",
issn = "1433-7851",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy

AU - Gee, Clifford T.

AU - Koleski, Edward J.

AU - Pomerantz, William C.K.

PY - 2015/3/16

Y1 - 2015/3/16

N2 - 19F NMR spectroscopy of labeled proteins is a sensitive method for characterizing structure, conformational dynamics, higher-order assembly, and ligand binding. Fluorination of aromatic side chains has been suggested as a labeling strategy for small-molecule ligand discovery for protein-protein interaction interfaces. Using a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX, we report the first full small-molecule screen using protein-observed 19F NMR spectroscopy. Screening of 508 compounds and validation by 1H-15N HSQC NMR spectroscopy led to the identification of a minimal pharmacaphore for the MLL-KIX interaction site. Hit rate analysis for the CREB-KIX and MLL-KIX sites provided a metric to assess the ligandability or "druggability" of each interface informing future medicinal chemistry efforts. The structural information from the simplified spectra and data collection speed, affords a new screening tool for analysis of protein interfaces and discovery of small molecules. A full small-molecule screen has been achieved using protein-observed 19F NMR (PrOF NMR) spectroscopy of a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX. This study demonstrates the applicability of PrOF NMR as a tool for library screening, ligand discovery, and druggability assessment.

AB - 19F NMR spectroscopy of labeled proteins is a sensitive method for characterizing structure, conformational dynamics, higher-order assembly, and ligand binding. Fluorination of aromatic side chains has been suggested as a labeling strategy for small-molecule ligand discovery for protein-protein interaction interfaces. Using a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX, we report the first full small-molecule screen using protein-observed 19F NMR spectroscopy. Screening of 508 compounds and validation by 1H-15N HSQC NMR spectroscopy led to the identification of a minimal pharmacaphore for the MLL-KIX interaction site. Hit rate analysis for the CREB-KIX and MLL-KIX sites provided a metric to assess the ligandability or "druggability" of each interface informing future medicinal chemistry efforts. The structural information from the simplified spectra and data collection speed, affords a new screening tool for analysis of protein interfaces and discovery of small molecules. A full small-molecule screen has been achieved using protein-observed 19F NMR (PrOF NMR) spectroscopy of a model transcription factor binding domain of the CREB binding protein (CBP)/p300, KIX. This study demonstrates the applicability of PrOF NMR as a tool for library screening, ligand discovery, and druggability assessment.

KW - biomolecular NMR

KW - fluorine

KW - fragment screening

KW - protein-protein interactions

KW - transcription

UR - http://www.scopus.com/inward/record.url?scp=84924373564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924373564&partnerID=8YFLogxK

U2 - 10.1002/anie.201411658

DO - 10.1002/anie.201411658

M3 - Article

C2 - 25651535

AN - SCOPUS:84924373564

VL - 54

SP - 3735

EP - 3739

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 12

ER -